• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗真菌药物的药代动力学和药效学

Pharmacokinetics and pharmacodynamics of antifungals.

作者信息

Andes David

机构信息

Department of Medicine, Infectious Diseases Section, University of Wisconsin, Madison, WI 53792, USA.

出版信息

Infect Dis Clin North Am. 2006 Sep;20(3):679-97. doi: 10.1016/j.idc.2006.06.007.

DOI:10.1016/j.idc.2006.06.007
PMID:16984875
Abstract

Application of pharmacodynamic principles to antifungal drug therapy of Candida and Aspergillus infections has provided and understanding of the relationship between drug dosing and treatment efficacy. Observations of the pharmacodynamics of triazoles and AmB have correlated with the results of clinical trials and have proven useful for validation of in vitro susceptibility breakpoints. Although there remain many unanswered questions regarding antifungal pharmacodynamics, available data suggest usefulness in the application of pharmacodynamics to antifungal clinical development. Future application of these principles should aid in the design of optimal combination antifungal therapies.

摘要

将药效学原理应用于念珠菌和曲霉菌感染的抗真菌药物治疗,有助于理解给药剂量与治疗效果之间的关系。对三唑类药物和两性霉素B药效学的观察结果与临床试验结果相关,并已证明有助于验证体外药敏试验的折点。尽管关于抗真菌药效学仍有许多未解决的问题,但现有数据表明将药效学应用于抗真菌临床开发是有用的。这些原理的未来应用应有助于设计最佳的联合抗真菌治疗方案。

相似文献

1
Pharmacokinetics and pharmacodynamics of antifungals.抗真菌药物的药代动力学和药效学
Infect Dis Clin North Am. 2006 Sep;20(3):679-97. doi: 10.1016/j.idc.2006.06.007.
2
Pharmacokinetics and pharmacodynamics in the development of antifungal compounds.抗真菌化合物研发中的药代动力学与药效学
Curr Opin Investig Drugs. 2003 Aug;4(8):991-8.
3
Clinical pharmacodynamics of antifungals.
Infect Dis Clin North Am. 2003 Sep;17(3):635-49. doi: 10.1016/s0891-5520(03)00063-1.
4
Antifungal pharmacokinetics and pharmacodynamics: understanding the implications for antifungal drug resistance.
Drug Resist Updat. 2004 Jun;7(3):185-94. doi: 10.1016/j.drup.2004.06.002.
5
Pharmacodynamic implications for use of antifungal agents.抗真菌药物使用的药效学意义。
Curr Opin Pharmacol. 2007 Oct;7(5):491-7. doi: 10.1016/j.coph.2007.05.004. Epub 2007 Jul 9.
6
CNS pharmacokinetics of antifungal agents.抗真菌药物的中枢神经系统药代动力学
Expert Opin Drug Metab Toxicol. 2007 Aug;3(4):573-81. doi: 10.1517/17425225.3.4.573.
7
Combination antifungals: an update.联合抗真菌药物:最新进展
Expert Rev Anti Infect Ther. 2007 Oct;5(5):883-92. doi: 10.1586/14787210.5.5.883.
8
Antifungal pharmacokinetics and pharmacodynamics: bridging from the bench to bedside.抗真菌药物的药代动力学和药效学:从实验室到临床的桥梁。
Clin Microbiol Infect. 2009 Jul;15(7):602-12. doi: 10.1111/j.1469-0691.2009.02913.x.
9
Antifungal serum concentration monitoring: an update.抗真菌血清浓度监测:最新进展
J Antimicrob Chemother. 2008 Jan;61(1):17-25. doi: 10.1093/jac/dkm389. Epub 2007 Nov 12.
10
Impact of pharmacodynamics and pharmacokinetics on echinocandin dosing strategies.药效学和药代动力学对棘白菌素给药策略的影响。
Curr Opin Infect Dis. 2007 Dec;20(6):587-91. doi: 10.1097/QCO.0b013e3282f1bea3.

引用本文的文献

1
Does infection alter antifungal distribution: an animal model exploring pharmacokinetic changes.感染是否会改变抗真菌药物的分布:一项探索药代动力学变化的动物模型研究。
Future Microbiol. 2025 Apr;20(6):489-498. doi: 10.1080/17460913.2025.2484956. Epub 2025 Apr 3.
2
Analysis of Personalized Cardiovascular Drug Therapy: From Monitoring Technologies to Data Integration and Future Perspectives.个性化心血管药物治疗分析:从监测技术到数据整合及未来展望
Biosensors (Basel). 2025 Mar 17;15(3):191. doi: 10.3390/bios15030191.
3
In Vitro Susceptibility Tests in the Context of Antifungal Resistance: Beyond Minimum Inhibitory Concentration in spp.
抗真菌耐药背景下的体外药敏试验:超越某菌属的最低抑菌浓度
J Fungi (Basel). 2023 Dec 12;9(12):1188. doi: 10.3390/jof9121188.
4
Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy.泊沙康唑在实验性侵袭性肺曲霉病中的药效学:血清半乳甘露聚糖作为抗真菌疗效的动态终点的实用性。
Antimicrob Agents Chemother. 2021 Jan 20;65(2). doi: 10.1128/AAC.01574-20.
5
Administration and Dosing of Systemic Antifungal Agents in Pediatric Patients.儿科患者全身用抗真菌药物的给药途径和剂量。
Paediatr Drugs. 2020 Apr;22(2):165-188. doi: 10.1007/s40272-020-00379-2.
6
Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.氟康唑联合氟胞嘧啶是治疗非 HIV 和非移植相关隐球菌性脑膜炎的一种较好的替代治疗方法:一项回顾性队列研究。
Mycoses. 2019 Aug;62(8):686-691. doi: 10.1111/myc.12944. Epub 2019 Jun 9.
7
Intravenous delivery of a liposomal formulation of voriconazole improves drug pharmacokinetics, tissue distribution, and enhances antifungal activity.静脉注射伏立康唑脂质体制剂可改善药物药代动力学、组织分布,并增强抗真菌活性。
Drug Deliv. 2018 Nov;25(1):1585-1594. doi: 10.1080/10717544.2018.1492046.
8
Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment.黄粉虫作为研究毛霉菌毒力潜能及抗真菌治疗评估的模型系统。
Med Mycol. 2019 Apr 1;57(3):351-362. doi: 10.1093/mmy/myy042.
9
Exploration of Antifungal and Immunomodulatory Potentials of a Furanone Derivative to Rescue Disseminated Cryptococosis in Mice.探讨呋喃酮衍生物的抗真菌和免疫调节潜力,以拯救小鼠播散性隐球菌病。
Sci Rep. 2017 Nov 13;7(1):15400. doi: 10.1038/s41598-017-15500-8.
10
Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis.新型口服活性抗真菌葡聚糖合成抑制剂SCY-078在播散性念珠菌病小鼠模型中的临床前药代动力学和药效学靶点
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02068-16. Print 2017 Apr.